14-3-3 eta/YWHAH Antibody (Rabbit mAb) [H13P22]

Catalog No.: F7263

    Application: Reactivity:
    • Lane 1: Hela, Lane 2: Jurkat, Lane 3: Mouse brain, Lane 4: Rat brain
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min

    使用情報

    Dilution
    1:1000
    1:20
    1:100
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    28 kDa 28 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human fetal brain tissue; Mouse brain tissue; Mouse spleen tissue; Rat brain tissue; Rat spleen tissue; Mouse heart tissue; Mouse kidney tissue; Rat heart tissue; Rat kidney tissue; Jurkat cells; PC-12 cells; NIH/3T3 cells
    ネガティブコントロール Human brain tissue

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    14-3-3 eta/YWHAH Antibody (Rabbit mAb) [H13P22] detects endogenous levels of total 14-3-3 eta/YWHAH protein.
    Uniprot ID
    Q04917
    Clone
    H13P22
    Synonym(s)
    YWHA1, YWHAH, 14-3-3 protein eta, Protein AS1
    Background
    14-3-3 eta (YWHAH) is a member of the conserved 14-3-3 adaptor family that forms phospho‑serine/phospho‑threonine–dependent dimers and functions as a soluble scaffold integrating multiple signaling pathways that control cell survival, metabolism, and stress responses, with particularly high expression in the nervous system and clear involvement in immune-mediated pathology. The protein adopts the typical 14-3-3 architecture of an antiparallel dimer built from α‑helical monomers, each containing a conserved amphipathic groove that recognizes RSXpSXP and related phosphopeptide motifs; binding of a phosphorylated client along this groove can mask functional sites, stabilize specific conformations, prevent dephosphorylation, or alter subcellular localization, thereby tuning activity and turnover of diverse kinases, transcription factors, and cytoskeletal regulators. In neurons, 14-3-3 proteins including the eta isoform interact directly with tau via multiple sites, promote its phosphorylation by a panel of tau kinases, and can induce aggregation of nonphosphorylated tau while protecting phosphorylated tau from dephosphorylation, which shifts the balance between microtubule binding and aggregate formation and positions 14-3-3 as an active participant in tau oligomerization and neurofibrillary tangle–related pathology. High neuronal abundance of 14-3-3 allows it to compete with tubulin for tau binding and to modulate the steady‑state levels and aggregation propensity of both wild-type and mutant tau, implicating YWHAH and related isoforms as contributors to tauopathies and as potential modulators of tau‑targeted strategies. In the immune system and joint microenvironment, 14-3-3 eta is released into synovial fluid and circulation where exogenous 14-3-3η can stimulate macrophages, monocytes, and fibroblast‑like synoviocytes, activating JAK–STAT, PI3K–AKT–mTOR, MAPK/ERK, JNK/AP‑1, and FOXO3–SNAI1 signaling cascades and inducing production of TNFα, IL‑6, CCL2, matrix metalloproteinases, and RANKL, all of which are central mediators of inflammation, cartilage degradation, and bone erosion in rheumatoid arthritis. In rheumatoid arthritis patients show that YWHAH mRNA is markedly upregulated in peripheral blood, and serum 14-3-3η levels strongly correlate with disease activity indices, autoantibody titers, hypoxia markers such as HIF‑1α, and angiogenic factors such as VEGF; carriers of a risk YWHAH rs2858750 allele exhibit higher 14-3-3η, greater inflammatory activity, and more severe disease, indicating that this isoform links intracellular signaling, synovial hypoxia, and angiogenesis to clinically measurable joint damage.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください